Song Y-Q, Zhang H-L, Huang H-Q, Zhang Q-Y, Jing H-M, Wang C, Wu C, Li D-H, Dai Y, Humphrey K, Zhu J. Glofitamab monotherapy induces high complete response rates and manageable safety in Chinese patients with heavily pretreated relapsed or refractory diffuse large B-cell lymphoma. haematol [Internet]. 2024Mar.31 [cited 2024May21];109(4):1269-73. Available from: https://haematologica.org/article/view/haematol.2023.283802